Exacerbation of lymphocytic choriomeningitis in mice treated with the inducible nitric oxide synthase inhibitor aminoguanidine

Journal of Neuroimmunology

Volumn 71, Issue 1-2, 1996, Pages 31-36

  Campbell, Iain L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

aminoguanidine; lymphocytic choriomeningitis virus; nitric oxide

Indexed keywords

AMINOGUANIDINE; CYTOKINE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; CYTOKINES; GUANIDINES; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED BALB C; NITRATES; NITRIC OXIDE SYNTHASE; NITRITES;

EID: 0030561017     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00129-4     Document Type: Article

References (32)

1. Ahmed R., Salmi A., Butler L.D., Chiller J.M., Oldstone M.B.A. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. J. Exp. Med. 60:1984;521-540.
2. + RNA. Biotechniques. 6:1988;114-116.
3. Baenziger J., Hengartner H., Zinkernagel R.M., Cole G.A. Induction or prevention of immunopathologic disease by cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur. J. Immunol. 16:1986;387-393.
4. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
5. Buchmeier M.J., Welsh R.M., Dutko F.J., Oldstone M.B.A. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:1980;275-331.
6. Campbell I.L., Hobbs M.V., Kemper P., Oldstone M.B.A. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J. Immunol. 152:1994;716-723.
7. Campbell I.L., Samimi A., Chiang C.-S. Expression of the inducible nitric oxide synthase. Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J. Immunol. 153:1994;3622-3629.
8. Choi D.W. Nitric oxide: Foe or friend to the injured brain? Proc. Natl. Acad. Sci. USA. 90:1993;9741-9743.
9. Corbett J.A., Mikhael A., Shimizu J., Frederick K., Misko T.P., McDaniel M.L., Kanagawa O., Unanue E.R. Nitric oxide production in islets from nonobese diabetic mice: Aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA. 90:1993;8992-8995.
10. Croen K.D. Evidence for an antiviral effect of nitric oxide: Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:1993;2446-2452.
11. Cross A.H.M., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
12. + immune cells. Cell Immunol. 107:1987;8-14.
13. + T cells. Immunol. Today. 11:1990;55-59.
14. Dutko F.J., Oldstone M.B.A. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Genet. Virol. 64:1983;1689-1698.
15. Florquin S., Amraoui Z., Dubois C., Decuyer J., Goldman M. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J. Exp. Med. 180:1994;1153-1158.
16. Galea E., Feinstein D.L., Reis D.J. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA. 89:1992;10945-10949.
17. Iadecola C. Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link? Trends Neurosci. 16:1993;206-214.
18. Karupian G., Xie Q.-w., Buller M.L., Nathan C., Duarte C., MacMicking J.D. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science. 261:1993;1445-1448.
19. Leist T.P., Cobbold S.P., Waldmann H., Zinkernagel R.M. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:1987;2278-2281.
20. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
21. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.-w., Sokol K., Hutchinson N., Chen H., Mudgett J.S. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
22. Misko T.P., Moore W.M., Kasten T.P., Nickols G.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:1993;119-125.
23. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:1993;2002-2012.
24. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61:1987;1867-1874.
25. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3063.
26. Nathan C., Xie Q.-w. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:1994;915-918.
27. Sicher S.C., Vazquez M.A., Lu C.Y. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1994;1293-1300.
28. Simmons M.L., Murphy S. Induction of nitric oxide synthase in glial cells. J. Neurochem. 59:1992;897-905.
29. Simmons M.L., Murphy S. Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur. J. Neurosci. 5:1993;825-831.
30. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P., Padron J., Phillips R.S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:1994;980-984.
31. Wej X.-Q., Charles I.G., Smith A., Ure J., Feng G.-J., Huang F.-P., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
32. Zielasek J., Jung S., Gold R., Liew F.Y., Toyka K.V., Hartung H.P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.